Researchers uncover the link between EVs and tissue damage

A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.

New Teva ad campaign focuses on patients struggling with psychiatric drug side effect

Teva is focused on growing its Austedo brand to treat tardive dyskinesia, a side effect of some mental health medications, jumpstarting this year with a

February 6, 2024

Vor shares new data for stem cell therapy; Melinta partners with Venatorx on antibiotic under FDA review

Plus, news about BeiGene, Zymeworks, Rznomics, and Adicet: Vor Bio shares early data for its gene-edited stem cell therapy: The company announced Thursday that its

November 11, 2023

Curaleaf Sells Stock at C$6

Curaleaf Announces C$16 Million Underwritten Offering of Subordinate Voting Shares NEW YORK, Sept. 28, 2023 /CNW/ – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.